Massicotte, Marie-Hélène <br/><br/>
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Jun 2013 
 - 2401-8 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2013-1115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Body Composition<br/>Carcinoma, Neuroendocrine<br/>Cross-Over Studies<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Muscle, Skeletal--metabolism<br/>Piperidines--adverse effects<br/>Protein Kinase Inhibitors--therapeutic use<br/>Quinazolines--adverse effects<br/>Thyroid Neoplasms--drug therapy